Lifeloc Technologies

What Lifeloc Technologies does

Lifeloc Technologies, Inc. is a Colorado-based (Wheat Ridge) public company founded in 1983 that designs and manufactures portable breath alcohol testers using proprietary fuel cell sensing technology. The company sells its instruments to four end markets — law enforcement (primary), workplace drug and alcohol compliance programs (primary), corrections facilities (secondary), and individual consumers (secondary) — through a direct enterprise field sales organization. FY2025 revenue was $9.027 million, up 6% from $8.538 million in FY2024, with Q1 2026 revenue of $2.294 million and gross margin improving to 43% from 40% on better pricing and product mix. The company employs 38 people (35 full-time, 3 part-time) and trades on OTCMKTS under the ticker LCTC.

Lifeloc's growth optionality rests on SpinDetect, a microfluidic centrifugal drug detection platform exclusively licensed from Sandia National Laboratories. SpinDetect is designed to isolate psychoactive delta-9-THC from inactive metabolites and deliver qualitative pass/fail results for roadside and workplace drug testing — addressing a pain point that conventional immunoassay drug tests cannot resolve. The reader is targeted at an initial list price of approximately $7,495 with recurring consumable test disks, creating a hybrid hardware-plus-consumable revenue model. Production tooling was completed in April 2026, an automated reagent-dispensing cleanroom was commissioned in June 2026, and commercial launch is planned for late 2026 or early 2027 beginning with U.S. forensic and international markets.

The company operates as an independent public entity following the February 2026 termination of its proposed acquisition of Electronic Systems Technology, Inc. after ELST shareholders failed to approve the transaction. In May 2026, Lifeloc secured $500,000 in debt financing from its Chairman of the Board and CFO at 10.5% interest to fund ongoing operations and SpinDetect commercialization. The wider strategic context is a global breath analyzer market projected to grow from $1.91 billion in 2024 to $4.83 billion by 2030 (16.72% CAGR) and a global drug screening market projected to reach $19.2 billion by 2030 (14.5% CAGR), with Lifeloc positioned by industry analysts as one of three leading breathalyzer vendors alongside Abbott Laboratories and Intoximeters.

Name

Lifeloc Technologies

Legal name

Lifeloc Technologies, Inc.

Website

https://lifeloc.com

Company type

Public

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Lifeloc Technologies is a Colorado-based public manufacturer of fuel cell portable breath alcohol testers serving law enforcement, workplace, corrections, and consumer markets, now developing the SpinDetect centrifugal drug detection platform licensed from Sandia National Laboratories for late 2026/early 2027 launch.

Ownership category

akta.pro rank

Headquarters

HQ city

Wheat Ridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Breathalyzer Hardware Sales: Sale of portable breathalyzers for law enforcement, workplace, corrections, and consumer markets. FY 2025 revenue of $9.027 million represents 6% growth from prior year.
2. SpinDetect Drug Analyzer: Planned commercial launch of SpinDetect centrifugal drug analyzer with consumable test disks. Initial reader list price approximately $7,495, targeting late 2026 or early 2027 commercial launch.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Lifeloc Technologies manufactures portable breath alcohol testers based on fuel cell sensor technology for law enforcement, workplace, corrections, and consumer markets. The company is commercializing SpinDetect, a microfluidic centrifugal drug analyzer licensed from Sandia National Laboratories that uses consumable test disks to deliver qualitative delta-9-THC pass/fail results for roadside and workplace drug testing.

Product overview

Lifeloc Technologies offers portable breathalyzers for law enforcement, workplace, corrections, and consumer markets. The company's primary focus is on breath alcohol testing devices. The emerging SpinDetect centrifugal drug analyzer, licensed from Sandia National Laboratories, represents a new microfluidic drug detection platform in development. The SpinDetect system uses consumable test disks and is designed to provide rapid on-site drug detection with delta-9-THC isolation capability.

Differentiator

Problem solved

Functional benefit

Brands

• SpinDetect™: Centrifugal drug analyzer for rapid on-site drug detection. A microfluidic drug detection platform licensed from Sandia National Laboratories with a qualitative delta-9-THC pass/fail test as the first product.

Products and services

• Portable Breathalyzers Portable breath alcohol testers using fuel cell sensor technology, sold to law enforcement agencies for DUI enforcement, employers for workplace safety compliance, correctional facilities for inmate monitoring, and consumers for personal alcohol monitoring.
• SpinDetect Centrifugal Drug Analyzer Microfluidic centrifugal drug detection platform licensed from Sandia National Laboratories that uses consumable test disks to isolate psychoactive delta-9-THC from inactive metabolites, delivering rapid qualitative pass/fail results for roadside, workplace, and forensic drug testing.

Quantifiable outcome

• Q1 2026 gross margin improved to 43% from 40% due to better pricing and product mix
• +1 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Sandia National LaboratoriescoreTechnology or Integration · 1 February 2026Licensed SpinDetect microfluidic drug detection platform from Sandia National Laboratories. This is a core technology partnership providing Lifeloc with its key new product platform for drug detection, enabling beta testing to begin in 2026 with commercial launch later that year.
• Electronic Systems Technology, Inc.minorStrategic or Co-development Partner · 1 October 2025Proposed merger with Electronic Systems Technology, Inc. was under investigation by shareholder advocacy firms and was ultimately terminated in February 2026 after ELST shareholders failed to approve the transaction at a special meeting. The merger was intended to expand market reach but did not close.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Abbott Laboratories: Diversified medical device/diagnostics giant named as a leading player in the breath analyzer market alongside Lifeloc. Overlaps in alcohol testing and broader diagnostics but operates across many other categories.
• Thermo Fisher Scientific: Dominant analytical instrument and laboratory diagnostics provider. Addresses the same drug-testing labs and forensic toxicology markets that are initial targets for Lifeloc's SpinDetect launch.

Emerging players

• OraSure Technologies: Developer of rapid diagnostic tests including oral fluid drug testing products. Overlaps with Lifeloc's planned SpinDetect entry into workplace and roadside drug testing, though using a non-microfluidic sampling modality.
• BACtrack: Consumer-focused portable breathalyzer brand competing with Lifeloc in the personal-use segment. Focuses on consumer/retail while Lifeloc skews B2B/government, so partial overlap.
• Akron Biotechnology / Akers Biosciences (now Akers ABAXIS etc.): Diagnostics developer historically focused on rapid workplace drug and alcohol screening tests. Partial overlap with Lifeloc's workplace drug testing segment served via SpinDetect.

Direct peers

• Intoximeters, Inc. One of the three leading players named alongside Lifeloc in law-enforcement breath alcohol testing. Directly competes with Lifeloc in fuel-cell breathalyzers sold to police, workplace and corrections markets.
• CMI Inc. Manufacturer of breath alcohol testers and intoxilyzers primarily used by law enforcement. Directly competes with Lifeloc in the evidentiary breathalyzer category.
• Drägerwerk (Dräger Alcotest): Global leader in evidentiary breath alcohol testers (Alcotest) used by police forces worldwide. Directly competes with Lifeloc's fuel-cell portable breathalyzers in law enforcement and workplace markets.
• MPD Inc. Manufacturer of breath alcohol instruments for law enforcement and corrections. Directly comparable niche competitor with similar product focus and customer base.

Others

• Quest Diagnostics: One of the largest workplace drug and alcohol testing reference laboratories in the U.S. Operates in the buyer's downstream — they are a key customer channel rather than direct device competitor, but their requirements shape Lifeloc's product roadmap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/_LifeGuard
• Facebookfacebook.com/Lifeloc
• LinkedInlinkedin.com/company/234999

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lifeloc Technologies